Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.
To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with PGD2
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).
Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Marcone S and Fitzgerald DJ | Proteomic identification of the candidate target proteins of 15-deoxy-delta12,14-prostaglandin J2. | 2013 | Proteomics | pmid:23606334 |
Tasaki M et al. | Inhibition of antigen-induced airway inflammation and hyperresponsiveness in guinea pigs by a selective antagonist of "chemoattractant receptor homologous molecule expressed on Th2 cells" (CRTH2). | 2013 | Eur J Pharm Sci | pmid:23624353 |
Taketomi Y et al. | Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis. | 2013 | Nat. Immunol. | pmid:23624557 |
Fernandez-Bustamante A et al. | Early increase in alveolar macrophage prostaglandin 15d-PGJ2 precedes neutrophil recruitment into lungs of cytokine-insufflated rats. | 2013 | Inflammation | pmid:23616184 |
Shyu RY et al. | H-rev107 regulates prostaglandin D2 synthase-mediated suppression of cellular invasion in testicular cancer cells. | 2013 | J. Biomed. Sci. | pmid:23687991 |
Hau CS et al. | Suppressive effects of antimycotics on thymic stromal lymphopoietin production in human keratinocytes. | 2013 | J. Dermatol. Sci. | pmid:23688403 |
Starkl P et al. | PLA2G3 promotes mast cell maturation and function. | 2013 | Nat. Immunol. | pmid:23685814 |
Sánchez-Gómez FJ et al. | Modulation of GSTP1-1 oligomerization by electrophilic inflammatory mediators and reactive drugs. | 2013 | Inflamm Allergy Drug Targets | pmid:23596995 |
Shashni B et al. | Glycolytic enzymes PGK1 and PKM2 as novel transcriptional targets of PPARγ in breast cancer pathophysiology. | 2013 | J Drug Target | pmid:23130662 |
Abraki SB et al. | Simultaneous inhibition of COX-2 and activation of PPAR-γ resulted in the same level and pattern of neuroprotection as they were targeted separately. | 2013 | J. Mol. Neurosci. | pmid:23132402 |
Shin J et al. | Negative control of mast cell degranulation and the anaphylactic response by the phosphatase lipin1. | 2013 | Eur. J. Immunol. | pmid:23065777 |
Zhao G et al. | Pivotal role of reactive oxygen species in differential regulation of lipopolysaccharide-induced prostaglandins production in macrophages. | 2013 | Mol. Pharmacol. | pmid:23071105 |
Philibert P et al. | Unilateral cryptorchidism in mice mutant for Ptgds. | 2013 | Hum. Mutat. | pmid:23076868 |
Kataoka N et al. | Indomethacin inhibits eosinophil migration to prostaglandin D2 : therapeutic potential of CRTH2 desensitization for eosinophilic pustular folliculitis. | 2013 | Immunology | pmid:23582181 |
Liu L et al. | Inhibition of oxidative stress-elicited AKT activation facilitates PPARγ agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells. | 2013 | PLoS ONE | pmid:24023668 |
Harizi H | The immunobiology of prostanoid receptor signaling in connecting innate and adaptive immunity. | 2013 | Biomed Res Int | pmid:24024207 |
Kim KH et al. | Nrf2 is essential for the expression of lipocalin-prostaglandin D synthase induced by prostaglandin D2. | 2013 | Free Radic. Biol. Med. | pmid:24029383 |
Endo S et al. | Rabbit 3-hydroxyhexobarbital dehydrogenase is a NADPH-preferring reductase with broad substrate specificity for ketosteroids, prostaglandin Dâ‚‚, and other endogenous and xenobiotic carbonyl compounds. | 2013 | Biochem. Pharmacol. | pmid:23994167 |
Quan GH et al. | Anti-allergic flavones from Arthraxon hispidus. | 2013 | Chem. Pharm. Bull. | pmid:23995356 |
Sharvit E et al. | Amplified inhibition of stellate cell activation pathways by PPAR-γ, RAR and RXR agonists. | 2013 | PLoS ONE | pmid:24098526 |
Alhouayek M et al. | Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6. | 2013 | Proc. Natl. Acad. Sci. U.S.A. | pmid:24101490 |
Chi Y et al. | [Effect of 15-deoxy-Δ(12), 14-prostaglandin J2 on the cytokines in the culture supernatant of bone marrow mesenchymal stem cells]. | 2013 | Zhongguo Shi Yan Xue Ye Xue Za Zhi | pmid:24370048 |
Bolton C et al. | N-Methyl-D-aspartate (NMDA) receptor involvement in central nervous system prostaglandin production during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE). | 2013 | Fundam Clin Pharmacol | pmid:22742874 |
Kattamuri PV et al. | Asymmetric synthesis of novel N-(1-phenyl-2,3-dihydroxypropyl)arachidonylamides and evaluation of their anti-inflammatory activity. | 2013 | Life Sci. | pmid:22820546 |
Parson HK et al. | Role of prostaglandin D2 and the autonomic nervous system in niacin-induced flushing. | 2013 | J Diabetes | pmid:22727040 |
Wu D et al. | Novel biphasic role of resolvin D1 on expression of cyclooxygenase-2 in lipopolysaccharide-stimulated lung fibroblasts is partly through PI3K/AKT and ERK2 pathways. | 2013 | Mediators Inflamm. | pmid:24174713 |
Choi HG et al. | Inhibition of prostaglandin Dâ‚‚ production by trihydroxy fatty acids isolated from Ulmus davidiana var. japonica. | 2013 | Phytother Res | pmid:23147809 |
Idborg H et al. | Effects of mPGES-1 deletion on eicosanoid and fatty acid profiles in mice. | 2013 | Prostaglandins Other Lipid Mediat. | pmid:23916744 |
Kurzynska A et al. | Peroxisome proliferator activated receptor ligands affect progesterone and 17β-estradiol secretion by porcine corpus luteum during early pregnancy. | 2014 | J. Physiol. Pharmacol. | pmid:25371531 |
Tsubosaka Y et al. | A deficiency in the prostaglandin D2 receptor CRTH2 exacerbates adjuvant-induced joint inflammation. | 2014 | J. Immunol. | pmid:25362177 |
Korbecki J et al. | Cyclooxygenase pathways. | 2014 | Acta Biochim. Pol. | pmid:25343148 |
Miller NR et al. | Sustained neuroprotection from a single intravitreal injection of PGJâ‚‚ in a nonhuman primate model of nonarteritic anterior ischemic optic neuropathy. | 2014 | Invest. Ophthalmol. Vis. Sci. | pmid:25298416 |
Savinainen JR et al. | Biochemical and pharmacological characterization of the human lymphocyte antigen B-associated transcript 5 (BAT5/ABHD16A). | 2014 | PLoS ONE | pmid:25290914 |
Moon TC et al. | Expression of DP2 (CRTh2), a prostaglandin Dâ‚‚ receptor, in human mast cells. | 2014 | PLoS ONE | pmid:25268140 |
Liu C et al. | 15d-PGJâ‚‚ decreases PGEâ‚‚ synthesis in HBx-positive liver cells by interfering EGR1 binding to mPGES-1 promoter. | 2014 | Biochem. Pharmacol. | pmid:25108236 |
Zhang S et al. | Prostaglandin D2 receptor D-type prostanoid receptor 2 mediates eosinophil trafficking into the esophagus. | 2014 | Dis. Esophagus | pmid:24165271 |
Kaplan J et al. | Pioglitazone reduces inflammation through inhibition of NF-κB in polymicrobial sepsis. | 2014 | Innate Immun | pmid:24029145 |
GarcÃa-Bueno B et al. | Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia. | 2014 | Schizophr Bull | pmid:23486748 |
Katsumata Y et al. | Endogenous prostaglandin D2 and its metabolites protect the heart against ischemia-reperfusion injury by activating Nrf2. | 2014 | Hypertension | pmid:24101662 |
Mello CF and Oliveira MS | Commentary on Kaushik et al.: Prostaglandin D2 is crucial for seizure suppression and postictal sleep. Novel evidence supporting a role for prostanoid receptors in seizure control. | 2014 | Exp. Neurol. | pmid:24814715 |
Casali CI et al. | Coordinate regulation between the nuclear receptor peroxisome proliferator-activated receptor-γ and cyclooxygenase-2 in renal epithelial cells. | 2014 | Biochem. Pharmacol. | pmid:24915420 |
Sturm EM et al. | Opposing roles of prostaglandin D2 receptors in ulcerative colitis. | 2014 | J. Immunol. | pmid:24929001 |
Steinke JW et al. | Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease. | 2014 | J. Immunol. | pmid:24890720 |
Iwanaga K et al. | Mast cell-derived prostaglandin D2 inhibits colitis and colitis-associated colon cancer in mice. | 2014 | Cancer Res. | pmid:24879565 |
Song Y et al. | [PPAR-γ agonist inhibits the expressions of chemokines induced by IFN-γ and TNF-α in renal tubular epithelial cells]. | 2014 | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | pmid:25001926 |
Shivers KY et al. | PACAP27 prevents Parkinson-like neuronal loss and motor deficits but not microglia activation induced by prostaglandin J2. | 2014 | Biochim. Biophys. Acta | pmid:24970746 |
Takeshima Y | [Development of novel therapeutic approaches for Duchenne muscular dystrophy]. | 2014 | No To Hattatsu | pmid:24738186 |
Kang ES et al. | 15-Deoxy-Δ(12,14)-prostaglandin J2 prevents oxidative injury by upregulating the expression of aldose reductase in vascular smooth muscle cells. | 2014 | Free Radic. Res. | pmid:24180671 |
Pierron A et al. | PGJ2 restores RA sensitivity in melanoma cells by decreasing PRAME and EZH2. | 2014 | J. Dermatol. Sci. | pmid:24289988 |
Tachikawa M et al. | Pharmacological significance of prostaglandin E2 and D2 transport at the brain barriers. | 2014 | Adv. Pharmacol. | pmid:25307222 |